Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Carpenter

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Nature Communications|October 29, 2024
Author Correction: Systematic identification of post-transcriptional regulatory modulesMatvei Khoroshkin, Andrey Buyan, Martin Dodel, et al.
Oncogenesis|April 21, 2018
MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancersAnastasia Wyce, Jeanne J Matteo, Shawn W Foley, et al.
Nature Communications|September 9, 2024
Systematic identification of post-transcriptional regulatory modulesMatvei Khoroshkin, Andrey Buyan, Martin Dodel, et al.
Annals of Emergency Medicine|November 2, 2010
NIH Roundtable on Emergency Trauma ResearchCharles B Cairns, Ronald V Maier, Opeolu Adeoye, et al.
Journal of Medicinal Chemistry|October 20, 2021
Cell-Based Drug Discovery: Identification and Optimization of Small Molecules that Reduce <i>c</i>-MYC Protein Levels in CellsJesús R Medina, Xinrong Tian, William H Li, et al.
Parasites & Vectors|September 5, 2014
Quantitative factors proposed to influence the prevalence of canine tick-borne disease agents in the United StatesRoger W Stich, Byron L Blagburn, Dwight D Bowman, et al.
Nature|September 15, 2015
BET inhibitor resistance emerges from leukaemia stem cellsChun Yew Fong, Omer Gilan, Enid Y N Lam, et al.
Nature Structural & Molecular Biology|June 14, 2016
Functional interdependence of BRD4 and DOT1L in MLL leukemiaOmer Gilan, Enid Y N Lam, Isabelle Becher, et al.
Journal for Immunotherapy of Cancer|December 30, 2025
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignanciesAdila Izgutdina, Tasfia Rashid, William C Temple, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell MalignanciesAdila Izgutdina, Tasfia Rashid, William C Temple, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Nature Communications|October 29, 2024
Author Correction: Systematic identification of post-transcriptional regulatory modulesMatvei Khoroshkin, Andrey Buyan, Martin Dodel, et al.
Oncogenesis|April 21, 2018
MEK inhibitors overcome resistance to BET inhibition across a number of solid and hematologic cancersAnastasia Wyce, Jeanne J Matteo, Shawn W Foley, et al.
Nature Communications|September 9, 2024
Systematic identification of post-transcriptional regulatory modulesMatvei Khoroshkin, Andrey Buyan, Martin Dodel, et al.
Annals of Emergency Medicine|November 2, 2010
NIH Roundtable on Emergency Trauma ResearchCharles B Cairns, Ronald V Maier, Opeolu Adeoye, et al.
Journal of Medicinal Chemistry|October 20, 2021
Cell-Based Drug Discovery: Identification and Optimization of Small Molecules that Reduce <i>c</i>-MYC Protein Levels in CellsJesús R Medina, Xinrong Tian, William H Li, et al.
Parasites & Vectors|September 5, 2014
Quantitative factors proposed to influence the prevalence of canine tick-borne disease agents in the United StatesRoger W Stich, Byron L Blagburn, Dwight D Bowman, et al.
Nature|September 15, 2015
BET inhibitor resistance emerges from leukaemia stem cellsChun Yew Fong, Omer Gilan, Enid Y N Lam, et al.
Nature Structural & Molecular Biology|June 14, 2016
Functional interdependence of BRD4 and DOT1L in MLL leukemiaOmer Gilan, Enid Y N Lam, Isabelle Becher, et al.
Journal for Immunotherapy of Cancer|December 30, 2025
Affinity-matured CD72-targeting nanobody CAR T cells enhance elimination of antigen-low B-cell malignanciesAdila Izgutdina, Tasfia Rashid, William C Temple, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell MalignanciesAdila Izgutdina, Tasfia Rashid, William C Temple, et al.
Pageof 7